Comparative Pharmacology
Head-to-head clinical analysis: A HYDROCORT versus DEXASPORIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: A HYDROCORT versus DEXASPORIN.
A-HYDROCORT vs DEXASPORIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Hydrocortisone is a corticosteroid hormone that binds to glucocorticoid receptors, modulating gene expression to suppress inflammation, inhibit immune response, and regulate metabolism.
Dexasporin is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It binds to the glucocorticoid receptor, leading to modulation of gene expression and inhibition of pro-inflammatory mediators such as prostaglandins and leukotrienes.
Adrenal insufficiency: oral 20-30 mg/day in divided doses; inflammatory conditions: 5-60 mg/day oral; IV/IM: hydrocortisone sodium succinate 50-100 mg every 4-6 hours.
1 to 2 mg/kg intramuscular or intravenous every 8 hours.
None Documented
None Documented
Terminal half-life: 1.5-2 hours (cortisol); clinical effect persists 8-12 hours due to glucocorticoid receptor binding
3-4 hours (prolonged to 10-15 hours in renal impairment; monitor CrCl <30 mL/min)
Renal (primarily as metabolites, <1% unchanged); biliary/fecal (<5%)
Renal excretion (80-90% unchanged), biliary/fecal (10-20%)
Category C
Category C
Corticosteroid
Corticosteroid/Antibiotic Combination